NovaBridge Biosciences American Depositary Shares
NBP
75 hedge funds and large institutions have $123M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 32 closing their positions.
3.92% less ownership
Funds ownership: 20.1% → 16.18% (-3.9%)
19% less call options, than puts
Call options by funds: $59K | Put options by funds: $73K
23% less funds holding
Funds holding: 97 → 75 (-22)
25% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 28
66% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 32
69% less capital invested
Capital invested by funds: $393M → $123M (-$270M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.57M |
| 2 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$3.8M |
| 3 |
Two Sigma Investments
New York
|
+$3.23M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.26M |
| 5 |
Renaissance Technologies
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$13.9M |
| 2 |
AC
Armistice Capital
New York
|
-$11.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.2M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$7.64M |
NBP Hedge Fund Activity: Q3 2022 in Review
75 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2022, worth a combined $123M — down 69% from $393M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of NBP and 11 opened new positions — a net loss of 21 holders — while 28 trimmed existing stakes and 21 added.
The largest buyer was Citadel Advisors, adding an estimated $4.57M. The largest seller was Artisan Partners, exiting entirely with an estimated $13.9M sold.
- 75 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2022, down from 97 in Q2 2022.
- Funds reported $123M of NovaBridge Biosciences American Depositary Shares stock for Q3 2022, down 69% quarter-over-quarter.
- 11 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2022 and 32 closed out, a net change of -21 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2022 was Citadel Advisors, an estimated $4.57M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2022 was Artisan Partners, an estimated $13.9M sold.
Based on aggregated 13F filings for Q3 2022.